Hay Fever News and Research

RSS

Hay fever (pollen allergy) is one of the most common kinds of allergies. About 35 million Americans suffer from hay fever. Pollen is made by trees, grasses, and weeds. During the spring, summer, and fall some plants release pollen into the air you breathe. Your symptoms might be different at different times of the year. It all depends on the kinds of plants that grow where you live and what allergies you have.

Link between childhood eczema and asthma calls for more aggressive therapies

According to research by Australian scientists there is a link between childhood eczema and the onset of asthma in adults.

7 Jul 2008

Traffic pollution linked to childhood allergies

New research from Germany has found a link between traffic pollution and childhood allergies.

16 Jun 2008

Probiotics provide hay fever hope

With the peak grass pollen season approaching, scientists can reveal that a daily dose of probiotic can change the immune status of people with hay fever.

2 Jun 2008

New hay fever jab promises year long relief for sufferers

Relief is in sight for millions of hay fever sufferers with the promise of a jab, which lasts for a year, that significantly reduces symptoms.

15 May 2008

Kids who get down and dirty with the dog have far fewer allergies

The latest research into childhood allergies suggests that having a pet in the home reduces the risk of children being sensitive to allergens.

29 Apr 2008

Immunotherapy could prevent allergic reactions to food

Researchers at National Jewish Medical and Research Center are conducting trials to evaluate a method to prevent allergic reactions to food.

17 Apr 2008

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

16 Apr 2008

Childhood allergies interfere with sleep

New research suggests that while allergies can make children unwell during the daytime they often also interfere with their sleep.

17 Mar 2008

FDA approves XYZAL (levocetirizine dihydrochloride) for allergies and chronic idiopathic urticaria

UCB and sanofi-aventis have announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria.

20 Feb 2008

Protein a possible key to allergy and asthma control

Activating a protein found on some immune cells seems to halt the cells' typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins researchers suggests.

3 Jan 2008

Contact with commonly used pesticides associated with greater asthma risk in farm women

New research on farm women has shown that contact with some commonly used pesticides in farm work may increase their risk of allergic asthma.

2 Jan 2008

New immune system discovery will help fight hay fever and other allergies

A mechanism which can lead to hay fever and other allergic reactions, by preventing the immune system from regulating itself properly, has been discovered by scientists.

28 Dec 2007

FDA approves formulations of Zyrtec (cetirizine HCl) for nonprescription use

The U.S. Food and Drug Administration has approved tablet, chewable tablet, and syrup formulations of Zyrtec (cetirizine HCl) for nonprescription use.

21 Nov 2007

FDA approves new nonprescription allergy drug Zyrtec-D

The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.

13 Nov 2007

Fraunhofer pharmaceutical agent speeds drug development

It takes a great deal of time and money to develop a new drug. At Biotechnica in Hanover from October 9 to 11, the Fraunhofer Life Sciences Alliance will demonstrate how a pharmaceutical agent can make its way more quickly from the research laboratory to the pharmacy.

8 Oct 2007

It's back to the dark ages...hookworms to treat asthma!

Modern medicine may have stopped short of blood-letting, leeches and purges but parasitic worms could be making a come-back!

17 Sep 2007

Breastfeeding offers no protection against asthma or allergies

New research says breastfeeding does not protect children against developing asthma or allergies.

12 Sep 2007

Breakthrough new asthma gene found

In a large-scale study conducted with 2,643 children, international researchers with the participation of the Department of Experimental Pneumology of Ruhr-University Bochum (RUB), Germany (Prof. Dr. Albrecht Bufe), have discovered a gene variant that contributes significantly to the risk of childhood asthma.

5 Jul 2007

New study on cat allergens and babies

The study published by Chih-Mei Chen et al. in the May edition of the distinguished Journal of Allergy and Clinical Immunology did not approve earlier papers, according to which contact with cat allergens during the first few months of a child's life has a protective effect.

4 May 2007

New assessment model gauges lung cancer risk

Clinicians may be one step closer to having a critical tool in identifying which smokers are at higher risk for developing lung cancer, the deadliest of all cancers, thanks to an assessment model generated by researchers at The University of Texas M. D. Anderson Cancer Center.

2 May 2007